| Issue |
Title |
| Vol 17, No 1 (2020) |
Evidence base regarding target levels of arterial pressure in patients after a stroke: focus on a geriatric population |
|
|
Ostroumova O.D., Cherniaeva M.S. |
| Vol 13, No 1 (2016) |
The validation of the questionnaire for the early detection of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension |
|
|
Valieva Z.S., Glukhova S.I., Martyniuk T.V., Chazova I.E. |
| Vol 16, No 3 (2019) |
Experience of the management of patients with pulmonary hypertension in the Republic of Karelia |
|
|
Ryabkov V.A., Vezikova N.N., Malygin A.N., Novozhilova N.V., Merenkov V.V. |
| Vol 15, No 2 (2018) |
Possibilities of treatment of patients with resistant arterial hypertension |
|
|
Shugushev Z.K., Maximkin D.A., Ryumina A.S. |
| Vol 13, No 3 (2016) |
Features of cutaneous microcirculatory blood flow in patients with pulmonary hypertension of different etiology |
|
|
Dolgova E.V., Fedorovich A.A., Martynyuk T.V., Rogoza A.N., Chazova I.E. |
| Vol 16, No 3 (2019) |
Clinical, functional and hemodynamic profile of patients with Eisenmenger syndrome in comparison with the group of idiopathic pulmonary hypertension, features of starting specific therapy choice |
|
|
Gratsianskaya S.E., Valieva Z.S., Zorin A.V., Martynyuk T.V. |
| Vol 11, No 4 (2014) |
The development of a screening questionnaire to improve the early detection of pulmonary arterial hypertension |
|
|
Valieva Z.S., Valeeva E.G., Glukhova S.I., Martynyuk T.V., Chazova I.E. |
| Vol 14, No 4 (2017) |
Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Parts II-V |
|
|
Chazova I.Y., Tyulyandin S.A., Vitsenia M.V., Poltavskaya M.G., Gilyarov M.Y., Martynyuk T.V., Ovchinnikov A.G., Panchenko E.P., Fedotkina Y.A., Stenina M.B., Trophimova O.P., Ageev F.T. |
| Vol 6, No 4 (2009) |
Candesartan in the prevention of cardiovascular catastrophes: emphasis on the pre-vention of stroke |
|
|
Drapkina O.M., Dikur O.N. |
| Vol 13, No 3 (2016) |
Control of cardiovascular risk in patients with diabetes |
|
|
Zhernakova Y.V., Chazova I.E. |
| Vol 11, No 3 (2014) |
Nebivolol for treatment patients with arterial hypertension |
|
|
Mikheeva O.M., Komisarenko I.A. |
| Vol 9, No 4 (2012) |
Diuretics in arterial hypertension: a focus on torasemide |
|
|
Baryshnikova G.A., Stepanova I.I. |
| Vol 6, No 4 (2009) |
The modern treatment of cardiovascular diseases with b-blockers - focus on the nebivolol. |
|
|
Evdokimova A.G., Ol'khin V.A., Evdokimov V.V., Zolotareva E.V., Khadzegova A.B. |
| Vol 14, No 2 (2017) |
Prevalence of hypertension in military age males according to physical evaluation results |
|
|
Melnik M.V., Uvarovskaya B.V., Makson I.P., Ivanov A.A. |
| Vol 12, No 4 (2015) |
A modern view of the place of b-blockers in the treatmentof cardiovascular disease: the choice of drug within a class is crucial |
|
|
Ostroumova O.D., Fomina V.M., Smolyarchuk E.A. |
| Vol 12, No 1 (2015) |
The rise of cardiac biomarkers due to planned PCI and 1-year prognosis in patients with stable coronary artery disease and arterial hypertension |
|
|
Mironova O.Y. |
| Vol 11, No 3 (2014) |
Pharmacoepidemiological study of recommendations of diuretics for the treatment of hypertension in the outpatient setting |
|
|
Ponomareva A.I., Kompaniets O.G., Linchak R.M., Nemirovskaya M.M., Strokan M.V., Babich A.E. |
| Vol 10, No 1 (2013) |
Left ventricular hypertrophy and renin-angiotensin-aldosterone system: AT1-receptor blockers are in the focus |
|
|
Barsukov A.V., Glukhovskoy D.V., Talantseva M.S., Bagaeva Z.V., Pronina E.V., Zobnina M.P., Sveklina T.S., Korovin A.E. |
| Vol 6, No 3 (2009) |
Prevention of cardiovascular events at patients with arterial hypertension at treatmentangiotensin-converting enzyme inhibitor. |
|
|
Kislyak O.A., Postnikova S.V. |
| Vol 15, No 1 (2018) |
Organoprotective properties of therapy by fixed combination of perindoprile and amlodipine in patients with arterial hypertension and diabetes mellitus type 2 |
|
|
Statsenko M.E., Turkina S.V., Titarenko M.N. |
| Vol 12, No 2 (2015) |
Efficacy and safety of different regimens of fixed combinationof perindopril 10 mg/indapamide 2.5 mg in patients with arterial hypertension |
|
|
Elfimova E.M., Aksenova A.V., Litvin A.Y., Chazova I.E. |
| Vol 11, No 3 (2014) |
Why occurrence of arterial hypertension with age becomes frequent? |
|
|
Poseliugina O.B., Poseliugina E.B., Al-Galban N. |
| Vol 10, No 3 (2013) |
Osobennosti techeniya serdechno-sosudistykh zabolevaniy i printsipy vybora ratsional'noy antigipertenzivnoy terapii u bol'nykh khronicheskoy obstruktivnoy bolezn'yu legkikh |
|
|
Napalkov D.A., Panferov A.S. |
| Vol 9, No 4 (2012) |
Electrical and viscoelastic parameters of erythrocytes in patients with different degrees of arterial hypertension |
|
|
Gromov A.A., Kruchinina M.V., Rabko A.V., Baum V.A., Generalov V.M. |
| Vol 3, No 2 (2006) |
Effektivnost' i bezopasnost' tsilazaprila u patsientov s arterial'noy gipertoniey, perenesshikh insul't i/ili tranzitornuyu ishemicheskuyu ataku |
|
|
Chazova I.E., Kolos I.P., Fedorova V.I., Pustovitova T.S., Ustyuzhanin D.V., Sinitsyn V.E., Starchina Y.A. |
| Vol 15, No 4 (2018) |
Evaluation of effectiveness and safety of the first Russian-manufactured generic bosentan use in patients with pulmonary arterial hypertension |
|
|
Arkhipova O.A., Gratsianskaya S.E., Martynyuk T.V. |
| Vol 13, No 4 (2016) |
A fixed combination of amlodipine and losartan: effectiveness and safety in abnormal weather conditions in patients with arterial hypertension |
|
|
Ageev F.T., Smirnova M.D., Fofanova T.V., Blankova Z.N., Vitsenya M.V., Tsybulskaya T.V., Neverova E.F., Samsonova N.S. |
| Vol 12, No 3 (2015) |
Gender differences renin-angiotensin-aldosterone system and its relation to humoral factors in patients with arterial hypertension |
|
|
Dadashova G.M. |
| Vol 11, No 4 (2014) |
Peculiarity of medical management of patients with arterial hypertension after liver transplantation |
|
|
Kosmacheva Y.D., Babich A.E. |
| Vol 11, No 2 (2014) |
Efficacy and safety of amlodipine and perindopril (Prestance) fixed combination in patients with arterial hypertension during the summer heat |
|
|
Chazova I.E., Ageev F.T., Smirnova M.D., Ageeva N.V., Fofanova T.V., Svirida O.N., Mikhailov G.V., Levin A.M., Revich B.A. |
| Vol 6, No 4 (2009) |
Amlodipine: its ability to reduce the risk of complications of arterial hypertension |
|
|
Runikhina N.K., Tkacheva O.N. |
| Vol 15, No 2 (2018) |
Nitrogen oxide biochemical pathway in pulmonary arterial hypertension therapy and REPLACE trial results |
|
|
Shmalts A.A., Gorbachevsky S.V. |
| Vol 12, No 4 (2015) |
Clinical effects of one-year physical training program in arterial hypertension patients of working age who have suffered acute myocardial infarction (Russian randomized controlled trial) |
|
|
Aronov D.M., Bubnova M.G., Krasnitskiy V.B., Ioseliani D.G., Grinshteyn Y.I., Gulyaeva S.F., Efremushkin G.G., Lyamina N.P. |
| Vol 11, No 3 (2014) |
The combination therapy in arterial hypertension: opportunities of the fixed combination of irbesartan andhydrochlorothiazide(Koaprovel’) |
|
|
Ostroumova O.D., Guseva T.F., Bondarets O.V. |
| Vol 10, No 2 (2013) |
Factors influencing compliance with lifestyle modification in an organized population |
|
|
Alekseeva T.S., Ogarkov M.Y., Skripchenko A.E., Yankin M.Y. |
| Vol 6, No 1 (2009) |
Arterial hypertension and treatment of non steroidal anti-inflammatory drugs: advantage amlodipin |
|
|
Ezhov M.V., Yezhov M.V. |
| Vol 14, No 1 (2017) |
Arterial hypertension treatment changes in Yaroslavl region: results obtained after 4 years of complex program of regional healthcare system’s improvement implementation |
|
|
Mozheyko M.E., Vigdorchik A.V., Eregin S.Y., Danilenko N.V., Klimovskaya I.M., Ramanathan K., Hughes D. |
| Vol 12, No 4 (2015) |
Torasemid in the treatment of cardiovascular disease: the optimal use in conditions of comorbidity |
|
|
Poteshkina N.G., Troshina A.A. |
| Vol 10, No 4 (2013) |
Modern approaches to combined therapy of arterial hypertension |
|
|
Napalkov D.A., Zhilenko A.V. |
| Vol 10, No 1 (2013) |
Hypertension treatment: Is there a place for b-adrenoblockers? |
|
|
Minushkina L.O. |
| Vol 3, No 1 (2006) |
Lechenie patsienta s arterial'noy gipertenziey i gipertrofiey levogo zheludochka |
|
|
Chazova I.E., Ratova L.G., Ataullakhanova D.M. |
| Vol 15, No 4 (2018) |
Organoprotection with arterial hypertension 2-3 degrees |
|
|
Afonicheva I.I., Melnik M.V., Knyazeva S.A., Kazyulin A.A. |
| Vol 14, No 3 (2017) |
The influence of Losartanum and Amlodipinum fixed combination use on cardiovascular complications risk factors seasonal variability in patients with arterial hypertension |
|
|
Smirnova M.D., Fofanova T.V., Ageev F.T., Blankova Z.N., Vicenia M.V., Barinova I.V. |
| Vol 11, No 3 (2014) |
Pleiotropic features of dihydropyridine calcium channel antagonists |
|
|
Anikin G.S. |
| Vol 11, No 2 (2014) |
National questionnaire of treatment compliance:testing and application in outpatient practice |
|
|
Fofanova T.V., Ageev F.T., Smirnova M.D., Svirida O.N., Kuzmina A.E., Thostov A.S., Nelyubina A.S. |
| Vol 10, No 2 (2013) |
Legochnaya arterial'naya gipertenziya: na puti ot ratsional'noy diagnostiki k vyboru effektivnoy lekarstvennoy terapii |
|
|
Chazova I.E., Martynyuk T.V. |
| Vol 6, No 2 (2009) |
Vozmozhnosti telmisartana v ANGIO- i KArdioprotektsii i uluchshenii pokazateley uglevodnogo obmena pri narushenii tolerantnosti k glyukoze |
|
|
Nedogoda S.V., Barykina I.N., Brel' U.A., Chalyabi T.A., Mazina G.V., Podol'skaya E.V., Ledyaeva A.A. |
| Vol 6, No 1 (2009) |
Possible combinations of antihypertensive drugs at treatment of arterial hypertension at patientswith metabolic syndrome |
|
|
Mychka V.B., Chazova I.E., Mychka V.B., Chazova I.E. |
| Vol 13, No 2 (2016) |
Vascular stiffness in patients with arterial hypertension: possible antihypertensive therapy |
|
|
Ostroumova O.D., Kochetkov A.I., Lopukhina M.V. |
| Vol 11, No 4 (2014) |
Methods of sympathetic activity evaluation in patients with systemic refractory hypertension |
|
|
Grigin V.A., Danilov N.M., Sagaydak O.V., Shelkova G.V., Chazova I.Y. |
| Vol 10, No 4 (2013) |
Clinico-pharmacological aspects of metoprolol use |
|
|
Anikin G.S., Chernova I.M., Vinokurov V.G. |
| Vol 10, No 2 (2013) |
Sartans in the treatment of high-risk hypertension: the abilities of candesartan |
|
|
Morozova T.E. |
| Vol 3, No 2 (2006) |
Protivoishemicheskoe, antiaritmicheskoe i sosudistoe deystvie ingibitora angiotenzinprevrashchayushchego fermenta zofenoprila v eksperimente |
|
|
Shlyakhto E.V., Galagudza M.M., Syrenskiy A.V., Blokhin I.O., Konstantinov I.M., Nifontov E.M. |
| Vol 2, No 1 (2005) |
Effektivnost' i bezopasnost' primeneniya Betaloka ZOK i Logimaksa u bol'nykh myagkoy arterial'noy gipertenziey v sochetanii s khronicheskoy obstruktivnoy bolezn'yu legkikh |
|
|
Chazova I.E., Litvin A.Y., Galitsin P.V., Ageeva N.V., Ratova L.G. |
| Vol 16, No 4 (2019) |
Role of fixed combinations in modern treatment of arterial hypertension: new or well overlooked old? |
|
|
Adasheva T.V., Samorukova E.I., Zadionchenko V.S., Laricheva K.A. |
| Vol 6, No 3 (2009) |
Whether all ACE inhibitors enzyme are identical? Focus on zofenopril. |
|
|
Ratova L.G., Chazova I.E. |
| Vol 15, No 1 (2018) |
Pulmonary hypertension: reasonable selection of specific therapy |
|
|
Karoli N.A., Sazhnova S.I., Rebrov A.P. |
| Vol 14, No 1 (2017) |
Treatment of patients with high cardiovascular risk: a modern view on combined therapy |
|
|
Blankova Z.N., Aslanian N.S., Smolianinova N.G., Ageev F.T. |
| Vol 12, No 2 (2015) |
Fibromuscular dysplasia as the cause of malignant renovascular hypertension in a newborn |
|
|
Albot V.V., Dolgikh V.V., Gvak G.V., Pogodina A.V. |
| Vol 9, No 4 (2012) |
Iloprost for acute tests in patients with pulmonary arterial hypertension |
|
|
Belyatko E.A., Danilov N.M., Matchin Y.G., Martynyuk T.V., Chazova I.E. |
| Vol 3, No 1 (2006) |
Blokatory retseptorov k angiotenzinu II v lechenii diabeticheskoy nefropatii s pozitsiy dokazatel'noy meditsiny |
|
|
Shestakova M.V. |
| Vol 6, No 4 (2009) |
Direct renin inhibitors aliskiren - possibilities correction cardiorenal syndrome |
|
|
Chazova I.E., Fomin V.V. |
| Vol 12, No 3 (2015) |
Dependence of the efficiency of the initial state of fosinopril structure common carotid arteries, intravascular blood flow and central hemodynamics at patients with arterial hypertension |
|
|
Melnikova L.V., Bartosh L.F., Grechishkina O.A. |
| Vol 11, No 4 (2014) |
Dispersible Prestarium A tablets in the treatment of patients with arterial hypertension |
|
|
Malchikova S.V., Tarlovskaya Y.I. |
| Vol 11, No 1 (2014) |
Place of arterial hypertension in brain lesion development - from minor cognitive disorders to dementia |
|
|
Shishkova V.N. |
| Vol 6, No 4 (2009) |
The use of angiotensin receptor blocker losartan in the combinational therapy of arterial hypertension |
|
|
Zagidullin N.S., Zagidullin S.Z. |
| Vol 15, No 2 (2018) |
Endothelin receptor antagonist bosentan role in modern strategy for patients with pulmonary arterial hypertension treatment |
|
|
Arkhipova O.A., Martynyuk T.V. |
| Vol 12, No 1 (2015) |
Radiofrequency renal arteries denervation: waiting for reply |
|
|
Grigin V.A., Danilov N.M., Matchin Y.G., Shelkova G.V., Chazova I.E. |
| Vol 11, No 3 (2014) |
Comparative evaluation of zofenopril. Are the characteristics of angiotensin I converting enzyme inhibitors important for the practice? |
|
|
Kirichenko A.A. |
| Vol 10, No 4 (2013) |
Lercanidipine as a calcium antagonist of the third generation: a review of effectiveness in the hypertension treatment |
|
|
Zadionchenko V.S., Shekhyan G.G., Yalymov A.A., Varentsov S.I. |
| Vol 6, No 1 (2009) |
Ramipril - angiotensin converting enzyme ingibitor with a wide spectrum of therapeutic action |
|
|
Preobrazhenskiy, D.V., Preobrazhensky D.V., Vyshinskaja I.D., Vyshinskaya I.D. |
| Vol 11, No 4 (2014) |
Perindopril - angiotensin-converting enzyme inhibitor is approved for usage |
|
|
Napalkov D.A. |
| Vol 10, No 4 (2013) |
Rational pharmacotherapy of hypertension. Urapidil potential |
|
|
Morozova T.E., Andruschishina T.B., Shmarova D.G. |
| Vol 6, No 4 (2009) |
The improved form perindopril in treatment of arterial hypertension in various clinical situations (PREMIA) |
|
|
Mychka V.B., Zhernakova Y.V., Chazova I.E. |
| Vol 12, No 1 (2015) |
The meaning of hypertensive therapy choice in the correction of cerebral affection: from mild cognitive impairment to dementia |
|
|
Shishkova V.N. |
| Vol 11, No 3 (2014) |
Perindopril is angiotensin-converting enzyme inhibitor in treatment patients with arterial hypertension |
|
|
Martynov A.I., Urlaeva I.V., Akatova Y.V., Nikolin O.P. |
| Vol 11, No 2 (2014) |
Study of the relationship social and psychological characteristics of hypertensive patients, the frequency of medical emergencies and adherence of patients to treatment |
|
|
Chumakova E.A., Gaponova N.I. |
| Vol 6, No 2 (2009) |
Combined low-dose therapy of arterial hypertension |
|
|
Stryuk R.I. |
| Vol 2, No 2 (2005) |
Kal'tsievye blokatory v profilaktike insul'ta |
|
|
Drapkina O.M. |
| Vol 6, No 3 (2009) |
Atherosclerotic stenos of renal arteries at patients with diabetes mellitus and arterial hypertension. |
|
|
Fomin V.V., Moiseev S.V., Shvetsov M.Y., Mukhin N.A. |
| Vol 12, No 2 (2015) |
The recommendations review concerning the maintenance of patients with arterial hypertension: evidence and expert opinions |
|
|
Samorodskaya I.V., Boitsov S.A. |
| Vol 10, No 4 (2013) |
Riociguatas the first innovative guanylatecyclase stimulators class drugs for pulmonary arterial hypertension patients treatment |
|
|
Chazova I.E., Martynyuk T.V. |
| Vol 10, No 2 (2013) |
Torasemide: additional benefits for postmenopausal women with arterial hypertension |
|
|
Tkacheva O.N., Runikhina N.K., Sharashkina N.V. |
| Vol 1, No 2 (2004) |
Kombinirovannaya terapiya arterial'noy gipertenzii s pozitsiy profilaktiki serdechno-sosudistykh oslozhneniy i patogeneza |
|
|
Boytsov S.A. |
| Vol 6, No 1 (2009) |
Up-to date view on -blocker in treatment of arterial hypertension with heart failure |
|
|
Gorokhovskaya G.N., Petina M.M., Nikolau E.G., Martynov A.I., Gorohovskaja G.N., Petina M.M., Nikolau E.G., Martynov A.I. |
| Vol 12, No 1 (2015) |
Treatment with perindopril in patients with arterial hypertension: improving compliance |
|
|
Anikin G.S., Minina E.S., Andreevskaya E.M. |
| Vol 11, No 4 (2014) |
Arterial hypertension and brain damage. New targets of therapy |
|
|
Yanishevskiy S.N., Mirnaya D.A., Andreyev R.V. |
| Vol 3, No 1 (2006) |
Vliyanie terapii bisoprololom na perfuziyu golovnogo mozga u bol'nykh s metabolicheskim sindromom |
|
|
Mychka V.B., Sergienko V.B., Gornostaev V.V., Dvoskina I.M., Chazova I.E. |
| Vol 15, No 4 (2018) |
Modern combination antihypertensive pharmacotherapy |
|
|
Mubarakshina O.A., Somova M.N., Batishcheva G.A. |
| Vol 14, No 4 (2017) |
Markers of early target-organ brain damage in essential arterial hypertension: the search continues. Possibilities of diffusion tensor magnetic resonance imaging |
|
|
Parfenov V.A., Ostroumova T.M., Ostroumova O.D., Perepelova E.M., Perepelov V.A. |
| Vol 13, No 3 (2016) |
The role of bisoprolol in the management of patients with arterial hypertension |
|
|
Nedogoda S.V. |
| Vol 12, No 3 (2015) |
Fixed dose combinations for the treatment arterial hypertension: the real way to improve control |
|
|
Morozova T.E., Andreev S.S. |
| Vol 6, No 2 (2009) |
Obstructive sleep apnea syndrome |
|
|
Litvin A.Y., Chazova I.E. |
| Vol 16, No 4 (2019) |
Radiofrequency denervation of the renal arteries in patients with resistant arterial hypertension: 3 years of observation experience |
|
|
Savelyeva N.Y., Zherzhova A.Y., Mikova E.V., Gapon L.I., Kolunin G.V., Krinochkin D.V. |
| Vol 6, No 1 (2009) |
Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients withtype 2 diabetes mellitus and mild hypertension:a sequential, randomized, double-blind clinical trial |
|
|
Giuseppe Derosa -., Arrigo FG Cicero -., Angela D'Angelo -., Elena Fogari -., Sibilla Salvadeo -., Alessia Gravina -., Ilaria Ferrari -., Raffaella Fassi -., Roberto Fogari -. |
| Vol 15, No 2 (2018) |
Stroke prevention in patients with atrial fibrillation and comorbidities |
|
|
Ostroumova O.D., Voevodina N.Y., Guseva T.F., Pavleeva E.E., Piksina G.F., Goloborodova I.V. |
| Vol 13, No 2 (2016) |
Diuretics in combination antihypertensive therapy: focus on forecast |
|
|
Chazova I.E., Martyniuk T.V. |
| Vol 11, No 3 (2014) |
Possibilities ARB II (sartans) in hypertensive patients |
|
|
Morozova T.E., Andrushchishina T.B., Gontarenko S.V. |
| Vol 10, No 4 (2013) |
The comparative analysis of therapy by «typical practice» and the fixed combination perindopril and indapamide an arterial hypertension with kidney insufficiency |
|
|
Shiganov S.V., Baev V.V., Shulbayev A.P. |
| Vol 1, No 1 (2004) |
Antigipertenzivnaya effektivnost' valsartana, vliyanie na sostoyanie tsentral'noy gemodinamiki i mikrotsirkulyatsii: vzglyad s pozitsiy organoprotektsii |
|
|
Podzolkov V.I., Bulatov V.A., Son E.A., Makolkin V.I. |
| 1 - 100 of 181 Items |
1 2 > >> |
